Abby Odle

1.1k total citations
15 papers, 156 citations indexed

About

Abby Odle is a scholar working on Infectious Diseases, Animal Science and Zoology and Molecular Biology. According to data from OpenAlex, Abby Odle has authored 15 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 5 papers in Animal Science and Zoology and 2 papers in Molecular Biology. Recurrent topics in Abby Odle's work include SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (8 papers) and Viral gastroenteritis research and epidemiology (5 papers). Abby Odle is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (8 papers) and Viral gastroenteritis research and epidemiology (5 papers). Abby Odle collaborates with scholars based in United States, Germany and Netherlands. Abby Odle's co-authors include Stanley Perlman, Jian Zheng, Lanying Du, Wanbo Tai, Lok-Yin Roy Wong, Xiujuan Zhang, Fang Li, Juan Shi, Jian Shang and Aaron M. LeBeau and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Virology.

In The Last Decade

Abby Odle

12 papers receiving 156 citations

Peers

Abby Odle
Sasha W. Tilles United States
Rui Qiao China
Jerren Ho United States
Sundaresh Shankar United States
Wilhelm Furnon United Kingdom
Shan-Lu Liu United States
Mansi Purwar United States
Abby Odle
Citations per year, relative to Abby Odle Abby Odle (= 1×) peers Xiangyang Ge

Countries citing papers authored by Abby Odle

Since Specialization
Citations

This map shows the geographic impact of Abby Odle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abby Odle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abby Odle more than expected).

Fields of papers citing papers by Abby Odle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abby Odle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abby Odle. The network helps show where Abby Odle may publish in the future.

Co-authorship network of co-authors of Abby Odle

This figure shows the co-authorship network connecting the top 25 collaborators of Abby Odle. A scholar is included among the top collaborators of Abby Odle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abby Odle. Abby Odle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Hartwig, Stacey M., Abby Odle, Lok-Yin Roy Wong, et al.. (2024). Respiratory syncytial virus infection provides protection against severe acute respiratory syndrome coronavirus challenge. Journal of Virology. 98(9). e0066924–e0066924.
2.
Wang, Gang, Abhishek Kumar Verma, Xiao‐Qing Guan, et al.. (2024). Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge. Journal of Virology. 98(9). e0037624–e0037624. 2 indexed citations
3.
Lowery, Shea A., Noah A. Schuster, Lok-Yin Roy Wong, et al.. (2024). Mouse hepatitis virus JHMV I protein is required for maximal virulence. Journal of Virology. 98(9). e0068024–e0068024. 1 indexed citations
4.
Shi, Juan, Jian Zheng, Xiujuan Zhang, et al.. (2024). A T cell–based SARS-CoV-2 spike protein vaccine provides protection without antibodies. JCI Insight. 9(5). 7 indexed citations
5.
Tan, Timothy J.C., Abhishek Kumar Verma, Abby Odle, et al.. (2024). Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike. Proceedings of the National Academy of Sciences. 121(15). e2317222121–e2317222121. 10 indexed citations
6.
Behera, P., et al.. (2024). Ubiquitination in viral entry and replication: Mechanisms and implications. Advances in virus research. 119. 1–38.
7.
Odle, Abby, Abhishek Kumar Verma, Alan Sariol, et al.. (2024). Tissue-resident memory T cells contribute to protection against heterologous SARS-CoV-2 challenge. JCI Insight. 9(23).
8.
Lei, Ruipeng, Enya Qing, Abby Odle, et al.. (2024). Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning. Nature Communications. 15(1). 4056–4056. 7 indexed citations
9.
Hoffmann, Markus, Lok-Yin Roy Wong, Prerna Arora, et al.. (2023). Omicron subvariant BA.5 efficiently infects lung cells. Nature Communications. 14(1). 3500–3500. 21 indexed citations
10.
Wong, Lok-Yin Roy, Abby Odle, Douglas C. Wu, et al.. (2023). Contrasting roles of MERS-CoV and SARS-CoV-2 internal proteins in pathogenesis in mice. mBio. 14(6). e0247623–e0247623. 4 indexed citations
11.
Shi, Juan, Jian Zheng, Wanbo Tai, et al.. (2022). A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection. Journal of Virology. 96(17). e0011822–e0011822. 19 indexed citations
12.
El‐Kafrawy, Sherif A., Abby Odle, Aymn T. Abbas, et al.. (2022). SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected mice. PLoS Pathogens. 18(9). e1010782–e1010782. 12 indexed citations
13.
Shi, Juan, Jian Zheng, Xiujuan Zhang, et al.. (2022). RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge. Translational research. 248. 11–21. 15 indexed citations
14.
Sariol, Alan, Laura Collins, Abby Odle, et al.. (2021). Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID ‐19 convalescent plasma donors. Transfusion. 61(7). 2099–2106. 18 indexed citations
15.
Ye, Gang, Jian Zheng, Ke Shi, et al.. (2021). The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates. eLife. 10. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026